GABA Pathways in Autism Spectrum Disorder (ASD)

• Status: Unknown status
• Trial end date: 2021-09-14

Summary

This study investigates the brain response to a single acute dose of AZD7325, a GABA-A positive allosteric modulator, compared to a single dose of placebo in adults with and without autism spectrum disorder.

• Phase: N/A

Details

• Lead Sponsor: King's College London